Literature DB >> 33507830

Corneal Graft Rejection after Yellow Fever Vaccine: A Case Report.

Roberto Vignapiano1, Lidia Vicchio1, Eleonora Favuzza1, Michela Cennamo1, Rita Mencucci1.   

Abstract

PURPOSE: To report an unusual case of corneal graft rejection after yellow fever vaccine.
METHODS: Case report.
RESULTS: We have described the case of a 48-year-old man who developed a corneal graft rejection in the left eye 3 weeks after a yellow fever vaccination. The ophthalmic examination of the left eye revealed conjunctival hyperemia, corneal graft edema with Descemet folds, and fine keratic precipitates. No abnormalities were found in the right eye. The episode of graft rejection fully recovered after a short course of systemic and topical steroid treatment.
CONCLUSIONS: This is the first case report of corneal transplant rejection temporally associated with yellow fever vaccination. Although the yellow fever vaccine is a very safe and efficacious vaccine, the occurrence of vaccine-related rejection may be more frequent than reported. Both patients and ophthalmologists should be aware of possible vaccine-related complications which may be potentially sight-threatening.

Entities:  

Keywords:  Yellow fever vaccine; corneal transplant; graft rejection

Mesh:

Substances:

Year:  2021        PMID: 33507830     DOI: 10.1080/09273948.2020.1870146

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.728


  7 in total

Review 1.  Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective.

Authors:  Abid A Haseeb; Omar Solyman; Mokhtar M Abushanab; Ahmed S Abo Obaia; Abdelrahman M Elhusseiny
Journal:  Vaccines (Basel)       Date:  2022-02-21

Review 2.  Stromal rejection in penetrating keratoplasty following COVID-19 vector vaccine (Covishield) - A case report and review of literature.

Authors:  Rama Rajagopal; T Maria Priyanka
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 2.969

Review 3.  COVID-19 Vaccination and The Eye.

Authors:  Michael T M Wang; Rachael L Niederer; Charles N J McGhee; Helen V Danesh-Meyer
Journal:  Am J Ophthalmol       Date:  2022-02-25       Impact factor: 5.488

Review 4.  Characteristics and Clinical Ocular Manifestations in Patients with Acute Corneal Graft Rejection after Receiving the COVID-19 Vaccine: A Systematic Review.

Authors:  Kenta Fujio; Jaemyoung Sung; Satoru Nakatani; Kazuko Yamamoto; Masao Iwagami; Keiichi Fujimoto; Hurramhon Shokirova; Yuichi Okumura; Yasutsugu Akasaki; Ken Nagino; Akie Midorikawa-Inomata; Kunihiko Hirosawa; Maria Miura; Tianxiang Huang; Yuki Morooka; Mizu Kuwahara; Akira Murakami; Takenori Inomata
Journal:  J Clin Med       Date:  2022-08-02       Impact factor: 4.964

Review 5.  Acute corneal allograft rejection following SARS-CoV-2 vaccination-A systematic review.

Authors:  Nuno Moura-Coelho; João Paulo Cunha; Renato Papa-Vettorazzi; Óscar Gris; José Luis Güell
Journal:  Acta Ophthalmol       Date:  2022-07-04       Impact factor: 3.988

Review 6.  Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis.

Authors:  Saad Alhumaid; Ali A Rabaan; Kuldeep Dhama; Shin Jie Yong; Firzan Nainu; Khalid Hajissa; Nourah Al Dossary; Khulood Khaled Alajmi; Afaf E Al Saggar; Fahad Abdullah AlHarbi; Mohammed Buhays Aswany; Abdullah Abdulaziz Alshayee; Saad Abdalaziz Alrabiah; Ahmed Mahmoud Saleh; Mohammed Ali Alqarni; Fahad Mohammed Al Gharib; Shahd Nabeel Qattan; Hassan M Almusabeh; Hussain Yousef AlGhatm; Sameer Ahmed Almoraihel; Ahmed Saeed Alzuwaid; Mohammed Ali Albaqshi; Murtadha Ahmed Al Khalaf; Yasmine Ahmed Albaqshi; Abdulsatar H Al Brahim; Mahdi Mana Al Mutared; Hassan Al-Helal; Header A Alghazal; Abbas Al Mutair
Journal:  Vaccines (Basel)       Date:  2022-08-10

7.  Presumably Corneal Graft Rejection after COVID-19 Vaccination.

Authors:  Maryam Mohammadzadeh; Sadid Hooshmandi; Mina Jafari; Kiana Hassanpour
Journal:  Case Rep Ophthalmol       Date:  2022-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.